Or it could be that since the selling pressure is gone, now investors are actually buying to invest long term. For example, if you believe NGIO is worth at least the $300M valuation they had (via analysis), and GNBT keeps 75%, then they would hold $225Mnof NGIO. With 78.22M shares outstanding, and not giving anything else GNBT owns any value, then that $300M NGIO valuation would make GNBT worth $2.88 by itself. So buying at these prices would be very beneficial.
(1)
(0)
Generex Biotechnology Corp. (GNBTQ) Stock Research Links
Disclaimer: Of course, all of this is my opinion and you should not make any investment decisions based on my opinion. I have not received any non-public information.